Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
121825024	12182502	4	F	2016	20160804	20160316	20160812	EXP		JP-009507513-1602JPN011071	MERCK		69.00	YR		M	Y	0.00000		20160812		MD	JP	JP

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	CUM DOSE CHR	CUM DOSE UNIT	DECHAL	RECHAL	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
121825024	12182502	1	PS	BELSOMRA	SUVOREXANT	1	Oral	15 MG, QD	585	MG	Y		204569	15	MG	TABLET	QD
121825024	12182502	2	SS	LENDORMIN	BROTIZOLAM	1	Oral	0.25 MG, QD	11	MG	Y		0			TABLET	QD
121825024	12182502	3	SS	RHYTHMY	RILMAZAFONE HYDROCHLORIDE	1	Oral	2 MG, QD	312	MG			0	2	MG	TABLET	QD
121825024	12182502	4	SS	NEODOPASTON	CARBIDOPALEVODOPA	1	Oral	100 MG, TID					0	100	MG	TABLET	TID
121825024	12182502	5	SS	MIRAPEX	PRAMIPEXOLE DIHYDROCHLORIDE	1	Oral	0.375 MG, QD					0			TABLET	QD
121825024	12182502	6	SS	FP (selegiline hydrochloride)	SELEGILINE HYDROCHLORIDE	1	Oral	2.5 MG, QD	75	MG			0	2.5	MG	TABLET	QD
121825024	12182502	7	SS	CYMBALTA	DULOXETINE HYDROCHLORIDE	1	Oral	20 MG, QD	1820	MG			0	20	MG	CAPSULE	QD
121825024	12182502	8	SS	DOGMATYL	SULPIRIDE	1	Oral	50 MG, QD	3500	MG			0	50	MG	POWDER	QD
121825024	12182502	9	SS	DEPAS	ETIZOLAM	1	Oral	0.5 MG, BID	88	MG	Y		0	.5	MG	TABLET	BID
121825024	12182502	10	C	CONTOMIN	CHLORPROMAZINE	1	Oral	0.4 MG, TID	15.6000004	MG		U	0	.4	MG	TABLET	TID
121825024	12182502	11	C	MENESIT TABLETS - 100	CARBIDOPALEVODOPA	1	Oral	100 MG, TID	73200	MG	Y		0	100	MG	TABLET	TID
121825024	12182502	12	C	AMITIZA	LUBIPROSTONE	1	Oral	24 MICROGRAM, BID	.624	MG		U	0	24	UG	CAPSULE	BID

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
121825024	12182502	1	Insomnia
121825024	12182502	2	Insomnia
121825024	12182502	3	Insomnia
121825024	12182502	4	Parkinson's disease
121825024	12182502	5	Parkinson's disease
121825024	12182502	6	Parkinson's disease
121825024	12182502	7	Depression
121825024	12182502	8	Depression
121825024	12182502	9	Anxiety
121825024	12182502	10	Anxiety
121825024	12182502	11	Parkinson's disease
121825024	12182502	12	Constipation

Outcome of event

Reactions reported

Event ID	CASEID	PT
121825024	12182502	Infection
121825024	12182502	Interstitial lung disease
121825024	12182502	Renal impairment
121825024	12182502	Somnolence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
121825024	12182502	1	20160107	20160218
121825024	12182502	2	20160107	20160218
121825024	12182502	3	20150616	20151118
121825024	12182502	4		20150616
121825024	12182502	5		20150616
121825024	12182502	6	20150616	20150715
121825024	12182502	7	20151008	20160106
121825024	12182502	8	20151029	20160106
121825024	12182502	9	20151119	20160301
121825024	12182502	10	20160218	20160301
121825024	12182502	11	20150616	20160303
121825024	12182502	12	20160218	20160301